The use of hyperbaric oxygenation in treating viral hepatitis B and the reaction of the blood leukocytes. | Canada Hyperbarics Skip to main content
Clinical Study Terapevticheskii arkhiv 1990

The use of hyperbaric oxygenation in treating viral hepatitis B and the reaction of the blood leukocytes.

Gabrilovich DI, Musarov AL, Zmyzgova AV, Shalygina NB — Terapevticheskii arkhiv, 1990

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers examined 75 patients with medium-gravity viral hepatitis B to assess the effect of hyperbaric oxygenation (HBO) on disease progression and blood leukocyte reactions.

What They Found

Researchers found that hyperbaric oxygenation (HBO) administered during the first week of hospitalization favorably impacted 75 patients with viral hepatitis B, significantly reducing exacerbations and residual phenomena. HBO treatment led to a decrease in T and B lymphocytes by the 10th session and increased leukocyte functional metabolic activity. However, HBO used in weeks 4-5 showed no distinct clinical benefit.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A limitation of this study is the absence of a clearly defined control group for comparison and its single-center origin.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 2333627
Year Published 1990
Journal Terapevticheskii arkhiv
MeSH Terms Adolescent; Adult; Combined Modality Therapy; Evaluation Studies as Topic; Female; Hepatitis B; Humans; Hyperbaric Oxygenation; Leukocyte Count; Leukocytes; Male; Middle Aged; Neutrophils; Rosette Formation

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology